Design Therapeutics Competitors and Similar CompaniesClear all
Abliva's competitors and similar companies include Y-mAbs Therapeutics.
 Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. |  Y-mAbs Therapeutics Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets. | |
Founding Date | Founding Date 2000 | Founding Date 2014 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Lund, SE HQ | Locations New York, US HQ Copenhagen, DK Nutley, US |
Employees | Employees 950% increase | Employees 3239% increase |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $87.7m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $15m (FY, 2024) |
Gross profit | Gross profit kr497k (FY, 2024) | Gross profit $72.7m (FY, 2024) |
Net income | Net income (kr90m) (FY, 2024) | Net income ($29.7m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 10.8m | Total funding raised $ 80m |
For sources of this data, please see the company profile
View Company Profiles
Y-mAbs Therapeutics
HQ
New York, US
Employees
32↑ 39% increase
Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
View company